Indexes | Current issue | Disclaimer
Table of contents | Full text PDF (PDF 201 KB) | Previous article | Next article
Monica M Lahra and Rodney Enriquez
The reference laboratories of the National Neisseria Network, Australia report laboratory data on invasive meningococcal disease (IMD) cases confirmed by laboratory testing using culture and non-culture based techniques for the Australian Meningococcal Surveillance Programme (AMSP).
Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification testing (NAAT) and serological techniques, are defined as IMD according to Public Health Laboratory Network definitions.
Data contained in quarterly reports are restricted to a description of the numbers of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received.
A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the AMSP annual report published in CDI.
Jurisdiction |
Year |
Serogroup |
|||||||||||||
A |
B |
C |
Y |
W |
ND/other |
All |
|||||||||
Q2 |
ytd |
Q2 |
ytd |
Q2 |
ytd |
Q2 |
ytd |
Q2 |
ytd |
Q2 |
ytd |
Q2 |
ytd |
||
Australian Capital Territory |
2017 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2016 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
New South Wales |
2017 |
0 |
0 |
7 |
16 |
1 |
3 |
1 |
3 |
3 |
5 |
2 |
2 |
14 |
29 |
2016 |
0 |
0 |
5 |
10 |
0 |
1 |
4 |
4 |
5 |
9 |
0 |
3 |
14 |
27 |
|
Northern Territory |
2017 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
2 |
2016 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
|
Queensland |
2017 |
0 |
0 |
4 |
14 |
0 |
0 |
2 |
11 |
4 |
6 |
0 |
1 |
10 |
32 |
2016 |
0 |
0 |
2 |
6 |
0 |
0 |
2 |
6 |
3 |
4 |
0 |
0 |
7 |
16 |
|
South Australia |
2017 |
0 |
0 |
5 |
6 |
0 |
0 |
0 |
2 |
2 |
4 |
0 |
0 |
7 |
12 |
2016 |
0 |
0 |
5 |
11 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
5 |
12 |
|
Tasmania |
17 |
0 |
0 |
2 |
2 |
0 |
0 |
0 |
0 |
1 |
5 |
0 |
0 |
3 |
7 |
16 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
2 |
|
Victoria |
17 |
0 |
0 |
3 |
8 |
2 |
2 |
3 |
7 |
9 |
17 |
0 |
0 |
17 |
34 |
16 |
0 |
0 |
4 |
7 |
0 |
1 |
2 |
2 |
9 |
14 |
0 |
0 |
15 |
24 |
|
Western Australia |
17 |
0 |
0 |
2 |
5 |
0 |
1 |
0 |
0 |
2 |
6 |
0 |
1 |
4 |
13 |
16 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
3 |
|
Australia |
17 |
0 |
0 |
23 |
51 |
3 |
6 |
6 |
24 |
21 |
44 |
2 |
4 |
55 |
129 |
16 |
0 |
0 |
18 |
37 |
0 |
2 |
8 |
12 |
17 |
31 |
0 |
3 |
43 |
85 |
- Neisseria Reference Laboratory and World Health Organisation Collaborating Centre for STD, Sydney. Department of Microbiology, New South Wales Health Pathology, The Prince of Wales Hospital, Randwick, NSW Australia.
- School of Medical Sciences, Faculty of Medicine, The University of New South Wales, 2053 Australia for the National Neisseria Network, Australia.